Volitionrx (VNRX) Invested Capital (2019 - 2025)
Volitionrx's Invested Capital history spans 9 years, with the latest figure at -$28.9 million for Q4 2025.
- For Q4 2025, Invested Capital fell 11.14% year-over-year to -$28.9 million; the TTM value through Dec 2025 reached -$28.9 million, down 11.14%, while the annual FY2025 figure was -$28.9 million, 11.14% down from the prior year.
- Invested Capital reached -$28.9 million in Q4 2025 per VNRX's latest filing, down from -$28.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $34.4 million in Q1 2021 to a low of -$28.9 million in Q4 2025.
- Average Invested Capital over 5 years is -$2.4 million, with a median of -$1.3 million recorded in 2022.
- Peak YoY movement for Invested Capital: skyrocketed 189.97% in 2021, then plummeted 3717.5% in 2024.
- A 5-year view of Invested Capital shows it stood at $17.8 million in 2021, then plummeted by 116.91% to -$3.0 million in 2022, then crashed by 186.17% to -$8.6 million in 2023, then tumbled by 202.25% to -$26.0 million in 2024, then fell by 11.14% to -$28.9 million in 2025.
- Per Business Quant, the three most recent readings for VNRX's Invested Capital are -$28.9 million (Q4 2025), -$28.2 million (Q3 2025), and -$26.3 million (Q2 2025).